Table of Contents
Chapter 1 mHealth Market: Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 GVR’s internal database
1.3.2 Primary Research
1.4 Research Scope and Assumptions
1.5 List of Data Sources
Chapter 2 mHealth Market: Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global mHealth Snapshot
Chapter 3 mHealth Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 Global mHealth Market Analysis Tools
3.4.1 Industry Analysis – Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.4.3 Major Deals & Strategic Alliances Analysis
3.5 COVID-19 Impact on the market
Chapter 4. mHealth Market Segment Analysis, By Component, 2018 – 2030 (USD Million)
4.1. Definition and Scope
4.2. Component Segment Dashboard
4.3. Global mHealth Market, by Component, 2018 to 2030
4.4. Wearables & Connected Medical Devices
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Vital Sign Monitoring Devices
4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.2. Heart Rate Monitors
4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.3. Activity Monitors
4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.4. Electrocardiographs
4.4.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.5. Pulse Oximeters
4.4.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.6. Spirometers
4.4.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.7. Blood Pressure Monitors
4.4.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2.8. Others
4.4.2.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Sleep Monitoring Devices
4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.2. Sleep trackers.
4.4.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.3. Wrist Actigraphs
4.4.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.4. Polysomnographs
4.4.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3.5. Others
4.4.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Electrocardiographs Fetal and Obstetric Devices
4.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Neuromonitoring Devices
4.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5.2. Electroencephalographs
4.4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5.3. Electromyographs
4.4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5.4. Others
4.4.5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. mHealth Apps
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Medical Apps
4.5.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2. Women’s Health
4.5.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2.2. Fitness and Nutrition
4.5.2.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2.3. Menstrual Health
4.5.2.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2.4. Pregnancy Tracking & Postpartum Care
4.5.2.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2.5. Menopause
4.5.2.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2.6. Disease Management
4.5.2.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.2.7. Others
4.5.2.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3. Chronic Disease Management Apps
4.5.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3.2. Diabetes Management Apps
4.5.2.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3.3. Blood Pressure and ECG Monitoring Apps
4.5.2.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3.4. Mental Health Management Apps
4.5.2.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3.5. Cancer Management Apps
4.5.2.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3.6. Obesity Management Apps
4.5.2.3.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.3.7. Other Chronic Disease Management Apps
4.5.2.3.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.4. Personal Health Record Apps
4.5.2.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.5. Medication Management Apps
4.5.2.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.6. Diagnostic Apps
4.5.2.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.7. Remote Monitoring Apps
4.5.2.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2.8. Others (Medical Reference, Professional Networking, Healthcare Education)
4.5.2.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Fitness Apps
4.5.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Services
4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Monitoring Services
4.6.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2.2. Independent Aging Solutions
4.6.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2.3. Chronic Disease Management & Post-Acute Care Services
4.6.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Diagnosis Services
4.6.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.4. Healthcare Systems Strengthening Services
4.6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.5. Others
4.6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. MHealth Systems
4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.2. EHR
4.7.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.3. E-prescribing Systems
4.7.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Healthcare Analytics
4.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. mHealth Market: Segment Analysis, by End-use, 2018- 2030 (USD Million)
5.1. Definition and Scope
5.2. End-use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. Patients
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Providers
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Payers
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. mHealth Market: Segment Analysis, by Region, by Component, by End-use, 2018- 2030 (USD Million)
6.1. Definition & Scope
6.2. Regional Market Share Analysis, 2023 & 2030
6.3. Regional Market Dashboard
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. SWOT Analysis
6.6. North America
6.6.1. U.S.
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework
6.6.1.3. Competitive scenario
6.6.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.2. Canada
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework
6.7.1.3. Competitive scenario
6.7.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.6. Norway
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework
6.7.7.3. Competitive scenario
6.7.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
6.7.8. Denmark
6.7.8.1. Key country dynamics
6.7.8.2. Regulatory framework
6.7.8.3. Competitive scenario
6.7.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework
6.8.1.3. Competitive scenario
6.8.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.2. China
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.3. India
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive scenario
6.8.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.4. Australia
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework
6.8.4.3. Competitive scenario
6.8.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.5. South Korea
6.8.5.1. Key country dynamics
6.8.5.2. Regulatory framework
6.8.5.3. Competitive scenario
6.8.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
6.8.6. Singapore
6.8.6.1. Key country dynamics
6.8.6.2. Regulatory framework
6.8.6.3. Competitive scenario
6.8.6.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework
6.9.1.3. Competitive scenario
6.9.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Regulatory framework
6.10.1.3. Competitive scenario
6.10.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Regulatory framework
6.10.2.3. Competitive scenario
6.10.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Million)
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Regulatory framework
6.10.3.3. Competitive scenario
6.10.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Regulatory framework
6.10.4.3. Competitive scenario
6.10.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. List of Key Companies
7.3.1. Google, Inc.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Allscripts (Veradigm LLC)
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Apple, Inc.
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. AT&T Intellectual Property
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Veradigm LLC (formerly, Allscripts Healthcare Solutions)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Qualcomm Technologies, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Telefonica S.A.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Vodafone Group
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. SoftServe, Inc
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Samsung Electronics Co., Ltd.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. SeekMed
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Orange
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
|